Global Stem Cell Umbilical Cord Blood Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
Scope of the Report:
This report studies the Stem Cell Umbilical Cord Blood market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Stem Cell Umbilical Cord Blood market by product type and applications/end industries.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries, however patents for UCB stem cells are comparatively less in developing economies.
The global Stem Cell Umbilical Cord Blood market is valued at 19600 million USD in 2017 and is expected to reach 93400 million USD by the end of 2023, growing at a CAGR of 29.7% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Stem Cell Umbilical Cord Blood.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Stem Cell Umbilical Cord Blood market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Stem Cell Umbilical Cord Blood market by product type and applications/end industries.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries, however patents for UCB stem cells are comparatively less in developing economies.
The global Stem Cell Umbilical Cord Blood market is valued at 19600 million USD in 2017 and is expected to reach 93400 million USD by the end of 2023, growing at a CAGR of 29.7% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Stem Cell Umbilical Cord Blood.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Advanced Cell Technology
- California Stem Cell
- Cytori Therapeutics
- Mesoblast Limited
- Opexa Therapeutics
- Athersys
- Geron Corporation
- Neostem
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Public Cord Blood Banks
- Private Cord Blood Banks
- Cancer/ Oncology Diseases
- Chronic Leukemia
- Myelodysplastic Syndrome
- Blood Diseases
- Beta Thalassemia
- Sickle Cell Disease
- Wiskott-Aldrich
- Hurler Syndrome
- Sanfilippo Syndrome
1 STEM CELL UMBILICAL CORD BLOOD MARKET OVERVIEW
1.1 Product Overview and Scope of Stem Cell Umbilical Cord Blood
1.2 Classification of Stem Cell Umbilical Cord Blood by Types
1.2.1 Global Stem Cell Umbilical Cord Blood Revenue Comparison by Types (2017-2023)
1.2.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Types in 2017
1.2.3 Public Cord Blood Banks
1.2.4 Private Cord Blood Banks
1.3 Global Stem Cell Umbilical Cord Blood Market by Application
1.3.1 Global Stem Cell Umbilical Cord Blood Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cancer/ Oncology Diseases
1.3.3 Chronic Leukemia
1.3.4 Myelodysplastic Syndrome
1.3.5 Blood Diseases
1.3.6 Beta Thalassemia
1.3.7 Sickle Cell Disease
1.3.8 Wiskott-Aldrich
1.3.9 Hurler Syndrome
1.3.10 Sanfilippo Syndrome
1.4 Global Stem Cell Umbilical Cord Blood Market by Regions
1.4.1 Global Stem Cell Umbilical Cord Blood Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.5 Global Market Size of Stem Cell Umbilical Cord Blood (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Advanced Cell Technology
2.1.1 Business Overview
2.1.2 Stem Cell Umbilical Cord Blood Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.2 California Stem Cell
2.2.1 Business Overview
2.2.2 Stem Cell Umbilical Cord Blood Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cytori Therapeutics
2.3.1 Business Overview
2.3.2 Stem Cell Umbilical Cord Blood Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mesoblast Limited
2.4.1 Business Overview
2.4.2 Stem Cell Umbilical Cord Blood Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.5 Opexa Therapeutics
2.5.1 Business Overview
2.5.2 Stem Cell Umbilical Cord Blood Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.6 Athersys
2.6.1 Business Overview
2.6.2 Stem Cell Umbilical Cord Blood Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Athersys Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.7 Geron Corporation
2.7.1 Business Overview
2.7.2 Stem Cell Umbilical Cord Blood Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.8 Neostem
2.8.1 Business Overview
2.8.2 Stem Cell Umbilical Cord Blood Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Neostem Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET COMPETITION, BY PLAYERS
3.1 Global Stem Cell Umbilical Cord Blood Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Stem Cell Umbilical Cord Blood Players Market Share
3.2.2 Top 10 Stem Cell Umbilical Cord Blood Players Market Share
3.3 Market Competition Trend
4 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SIZE BY REGIONS
4.1 Global Stem Cell Umbilical Cord Blood Revenue and Market Share by Regions
4.2 North America Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.3 Europe Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.5 South America Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
5.1 North America Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
5.2 USA Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5.3 Canada Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5.4 Mexico Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6 EUROPE STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
6.1 Europe Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
6.2 Germany Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.3 UK Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.4 France Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.5 Russia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.6 Italy Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
7.1 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
7.2 China Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.3 Japan Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.4 Korea Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.5 India Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
8.1 South America Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
8.2 Brazil Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8.3 Argentina Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8.4 Colombia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE STEM CELL UMBILICAL CORD BLOOD BY COUNTRIES
9.1 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
9.2 Saudi Arabia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.3 UAE Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.4 Egypt Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.5 Nigeria Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.6 South Africa Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
10 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SEGMENT BY TYPE
10.1 Global Stem Cell Umbilical Cord Blood Revenue and Market Share by Type (2013-2018)
10.2 Global Stem Cell Umbilical Cord Blood Market Forecast by Type (2018-2023)
10.3 Public Cord Blood Banks Revenue Growth Rate (2013-2023)
10.4 Private Cord Blood Banks Revenue Growth Rate (2013-2023)
11 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SEGMENT BY APPLICATION
11.1 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2013-2018)
11.2 Stem Cell Umbilical Cord Blood Market Forecast by Application (2018-2023)
11.3 Cancer/ Oncology Diseases Revenue Growth (2013-2018)
11.4 Chronic Leukemia Revenue Growth (2013-2018)
11.5 Myelodysplastic Syndrome Revenue Growth (2013-2018)
11.6 Blood Diseases Revenue Growth (2013-2018)
11.7 Beta Thalassemia Revenue Growth (2013-2018)
11.8 Sickle Cell Disease Revenue Growth (2013-2018)
11.9 Wiskott-Aldrich Revenue Growth (2013-2018)
11.10 Hurler Syndrome Revenue Growth (2013-2018)
11.11 Sanfilippo Syndrome Revenue Growth (2013-2018)
12 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SIZE FORECAST (2018-2023)
12.1 Global Stem Cell Umbilical Cord Blood Market Size Forecast (2018-2023)
12.2 Global Stem Cell Umbilical Cord Blood Market Forecast by Regions (2018-2023)
12.3 North America Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.4 Europe Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.6 South America Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Stem Cell Umbilical Cord Blood
1.2 Classification of Stem Cell Umbilical Cord Blood by Types
1.2.1 Global Stem Cell Umbilical Cord Blood Revenue Comparison by Types (2017-2023)
1.2.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Types in 2017
1.2.3 Public Cord Blood Banks
1.2.4 Private Cord Blood Banks
1.3 Global Stem Cell Umbilical Cord Blood Market by Application
1.3.1 Global Stem Cell Umbilical Cord Blood Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cancer/ Oncology Diseases
1.3.3 Chronic Leukemia
1.3.4 Myelodysplastic Syndrome
1.3.5 Blood Diseases
1.3.6 Beta Thalassemia
1.3.7 Sickle Cell Disease
1.3.8 Wiskott-Aldrich
1.3.9 Hurler Syndrome
1.3.10 Sanfilippo Syndrome
1.4 Global Stem Cell Umbilical Cord Blood Market by Regions
1.4.1 Global Stem Cell Umbilical Cord Blood Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Stem Cell Umbilical Cord Blood Status and Prospect (2013-2023)
1.5 Global Market Size of Stem Cell Umbilical Cord Blood (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Advanced Cell Technology
2.1.1 Business Overview
2.1.2 Stem Cell Umbilical Cord Blood Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.2 California Stem Cell
2.2.1 Business Overview
2.2.2 Stem Cell Umbilical Cord Blood Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cytori Therapeutics
2.3.1 Business Overview
2.3.2 Stem Cell Umbilical Cord Blood Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mesoblast Limited
2.4.1 Business Overview
2.4.2 Stem Cell Umbilical Cord Blood Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.5 Opexa Therapeutics
2.5.1 Business Overview
2.5.2 Stem Cell Umbilical Cord Blood Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.6 Athersys
2.6.1 Business Overview
2.6.2 Stem Cell Umbilical Cord Blood Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Athersys Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.7 Geron Corporation
2.7.1 Business Overview
2.7.2 Stem Cell Umbilical Cord Blood Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
2.8 Neostem
2.8.1 Business Overview
2.8.2 Stem Cell Umbilical Cord Blood Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Neostem Stem Cell Umbilical Cord Blood Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET COMPETITION, BY PLAYERS
3.1 Global Stem Cell Umbilical Cord Blood Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Stem Cell Umbilical Cord Blood Players Market Share
3.2.2 Top 10 Stem Cell Umbilical Cord Blood Players Market Share
3.3 Market Competition Trend
4 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SIZE BY REGIONS
4.1 Global Stem Cell Umbilical Cord Blood Revenue and Market Share by Regions
4.2 North America Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.3 Europe Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.5 South America Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
5.1 North America Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
5.2 USA Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5.3 Canada Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
5.4 Mexico Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6 EUROPE STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
6.1 Europe Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
6.2 Germany Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.3 UK Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.4 France Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.5 Russia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
6.6 Italy Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
7.1 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
7.2 China Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.3 Japan Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.4 Korea Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.5 India Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA STEM CELL UMBILICAL CORD BLOOD REVENUE BY COUNTRIES
8.1 South America Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
8.2 Brazil Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8.3 Argentina Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
8.4 Colombia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE STEM CELL UMBILICAL CORD BLOOD BY COUNTRIES
9.1 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue by Countries (2013-2018)
9.2 Saudi Arabia Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.3 UAE Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.4 Egypt Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.5 Nigeria Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
9.6 South Africa Stem Cell Umbilical Cord Blood Revenue and Growth Rate (2013-2018)
10 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SEGMENT BY TYPE
10.1 Global Stem Cell Umbilical Cord Blood Revenue and Market Share by Type (2013-2018)
10.2 Global Stem Cell Umbilical Cord Blood Market Forecast by Type (2018-2023)
10.3 Public Cord Blood Banks Revenue Growth Rate (2013-2023)
10.4 Private Cord Blood Banks Revenue Growth Rate (2013-2023)
11 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SEGMENT BY APPLICATION
11.1 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2013-2018)
11.2 Stem Cell Umbilical Cord Blood Market Forecast by Application (2018-2023)
11.3 Cancer/ Oncology Diseases Revenue Growth (2013-2018)
11.4 Chronic Leukemia Revenue Growth (2013-2018)
11.5 Myelodysplastic Syndrome Revenue Growth (2013-2018)
11.6 Blood Diseases Revenue Growth (2013-2018)
11.7 Beta Thalassemia Revenue Growth (2013-2018)
11.8 Sickle Cell Disease Revenue Growth (2013-2018)
11.9 Wiskott-Aldrich Revenue Growth (2013-2018)
11.10 Hurler Syndrome Revenue Growth (2013-2018)
11.11 Sanfilippo Syndrome Revenue Growth (2013-2018)
12 GLOBAL STEM CELL UMBILICAL CORD BLOOD MARKET SIZE FORECAST (2018-2023)
12.1 Global Stem Cell Umbilical Cord Blood Market Size Forecast (2018-2023)
12.2 Global Stem Cell Umbilical Cord Blood Market Forecast by Regions (2018-2023)
12.3 North America Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.4 Europe Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.6 South America Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Stem Cell Umbilical Cord Blood Picture
Table Product Specifications of Stem Cell Umbilical Cord Blood
Table Global Stem Cell Umbilical Cord Blood and Revenue (Million USD) Market Split by P
Figure Stem Cell Umbilical Cord Blood Picture
Table Product Specifications of Stem Cell Umbilical Cord Blood
Table Global Stem Cell Umbilical Cord Blood and Revenue (Million USD) Market Split by P
